Patents by Inventor Laurent Jacob

Laurent Jacob has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240096495
    Abstract: The present invention provides a powerful tool to identify personalized therapeutic strategies. In particular, the invention provides methods for determining therapeutically targetable dominant signaling pathways in a cancer sample from a subject affected with a solid cancer, determining a treatment protocol for the subject, selecting a subject for a therapy, determining whether the subject is susceptible to benefit from a therapy, predicting clinical outcome of the subject, treating the subject and/or predicting the sensitivity of a solid cancer to a therapy.
    Type: Application
    Filed: November 16, 2023
    Publication date: March 21, 2024
    Inventors: DOMINIQUE BAGNARD, AURORE FERNANDEZ, LAURENT JACOB, JUSTINE FRITZ
  • Patent number: 11823799
    Abstract: The present invention provides a powerful tool to identify personalized therapeutic strategies. In particular, the invention provides methods for determining therapeutically targetable dominant signaling pathways in a cancer sample from a subject affected with a solid cancer, determining a treatment protocol for the subject, selecting a subject for a therapy, determining whether the subject is susceptible to benefit from a therapy, predicting clinical outcome of the subject, treating the subject and/or predicting the sensitivity of a solid cancer to a therapy.
    Type: Grant
    Filed: November 21, 2016
    Date of Patent: November 21, 2023
    Assignees: UNIVERSITE DE STRASBOURG, INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)
    Inventors: Dominique Bagnard, Aurore Fernandez, Laurent Jacob, Justine Fritz
  • Publication number: 20230275966
    Abstract: A system and method for processing user requests of a user device by a plurality of networked computing devices is provided. The method involves: (a) receiving a first user request by a first computing device; (b) determining whether the first computing device is optimally selected for processing the user requests; (c) if not optimally selected, selecting from among the networked computing devices an optimal device having an optimal response time; and (d) directing subsequent user requests from the user device to the optimal device. A system and method for maintaining a computing process executable by a computing device is provided. The method involves: (a) receiving by a maintenance device a status indication associated with the computing process; (b) determining one or more proposed actions associated with the status indication; (c) selecting a maintenance action from among the proposed actions; and (d) executing the maintenance action at the computing device.
    Type: Application
    Filed: October 2, 2019
    Publication date: August 31, 2023
    Applicant: Ormuco Inc.
    Inventors: Orlando BAYTER, Laurent JACOB, Genevieve NANTEL, Bruca LOCK, Gaetan TRELLU, Pierre BLANC, Francisco Tomas ORTEGA
  • Publication number: 20180357364
    Abstract: The present invention provides a powerful tool to identify personalized therapeutic strategies. In particular, the invention provides methods for determining therapeutically targetable dominant signaling pathways in a cancer sample from a subject affected with a solid cancer, determining a treatment protocol for the subject, selecting a subject for a therapy, determining whether the subject is susceptible to benefit from a therapy, predicting clinical outcome of the subject, treating the subject and/or predicting the sensitivity of a solid cancer to a therapy.
    Type: Application
    Filed: November 21, 2016
    Publication date: December 13, 2018
    Inventors: DOMINIQUE BAGNARD, AURORE FERNANDEZ, LAURENT JACOB, JUSTINE FRITZ
  • Publication number: 20040186425
    Abstract: A power assisted method and injector device for controllably delivering to patients a dispersion medicament or diagnostically active agent, the homogeneity of which is preserved throughout delivery. Diagnostically active agents disclosed are gas microbubble suspensions useful in ultrasonic diagnostic imaging and liposomal formulations in which liposome vesicles are loaded with iodinated compounds.
    Type: Application
    Filed: January 30, 2004
    Publication date: September 23, 2004
    Inventors: Michel Schneider, Christophe Golay, Laurent Jacob, Jean Brochot, Feng Yan, Christian Mathieu
  • Publication number: 20030195491
    Abstract: A power assisted method and injector device for controllably delivering to patients a dispersion medicament or diagnostically active agent, the homogeneity of which is preserved throughout delivery. Diagnostically active agents disclosed are gas microbubble suspensions useful in ultrasonic diagnostic imaging and liposomal formulations in which liposome vesicles are loaded with iodinated compounds.
    Type: Application
    Filed: May 13, 2003
    Publication date: October 16, 2003
    Applicant: Bracco Research S.A.
    Inventors: Michel Schneider, Christophe Golay, Laurent Jacob, Jean Brochot, Feng Yan, Christian Mathieu